Literature DB >> 28055052

Metformin Use in Patients With Historical Contraindications.

Kasia J Lipska1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28055052      PMCID： PMC5334793          DOI： 10.7326/M16-2712

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  The impact of comorbid chronic conditions on diabetes care.

Authors:  John D Piette; Eve A Kerr
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

2.  Metformin in heart failure.

Authors:  Silvio E Inzucchi; Frederick A Masoudi; Darren K McGuire
Journal:  Diabetes Care       Date:  2007-12       Impact factor: 19.112

3.  Lactic acidosis in patients with diabetes treated with metformin.

Authors:  R I Misbin; L Green; B V Stadel; J L Gueriguian; A Gubbi; G A Fleming
Journal:  N Engl J Med       Date:  1998-01-22       Impact factor: 91.245

4.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; John M Lachin; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2016-03-17       Impact factor: 91.245

5.  Citizen Petition to the US Food and Drug Administration to Change Prescribing Guidelines: The Metformin Experience.

Authors:  Kasia J Lipska; James H Flory; Sean Hennessy; Silvio E Inzucchi
Journal:  Circulation       Date:  2016-11-01       Impact factor: 29.690

Review 6.  Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.

Authors:  Wendy L Bennett; Nisa M Maruthur; Sonal Singh; Jodi B Segal; Lisa M Wilson; Ranee Chatterjee; Spyridon S Marinopoulos; Milo A Puhan; Padmini Ranasinghe; Lauren Block; Wanda K Nicholson; Susan Hutfless; Eric B Bass; Shari Bolen
Journal:  Ann Intern Med       Date:  2011-03-14       Impact factor: 25.391

7.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

Review 9.  Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.

Authors:  Matthew J Crowley; Clarissa J Diamantidis; Jennifer R McDuffie; C Blake Cameron; John W Stanifer; Clare K Mock; Xianwei Wang; Shuang Tang; Avishek Nagi; Andrzej S Kosinski; John W Williams
Journal:  Ann Intern Med       Date:  2017-01-03       Impact factor: 25.391
  9 in total
  1 in total

1.  Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.

Authors:  Gian Paolo Fadini; Vera Frison; Natalino Simioni; Annunziata Lapolla; Adriano Gatti; Antonio Carlo Bossi; Andrea Del Buono; Paolo Fornengo; Lucia Gottardo; Mario Laudato; Gianluca Perseghin; Enzo Bonora; Angelo Avogaro
Journal:  J Am Heart Assoc       Date:  2019-07-04       Impact factor: 5.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.